New research highlights Transpara Detection's impact on the MASAI trial's final endpoint: interval cancers
The Lancet publishes final results from the first randomized controlled trial in Breast AI
New research highlights Transpara Detection's impact on the MASAI trial's final endpoint: interval cancers